TP53 and neoplasm: In summary, AURKBi treatment of RB+p53 defective tumour cells efficiently promotes hyper-polyploidy, treatment for at least 2 failed cell divisions is sufficient to drive hyper-polyploidy, and these hyper-polyploid cells cannot undergo reductive mitosis and do not produce daughter cells with long-term proliferative potential.